Teleflex (NYSE:TFX – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Piper Sandler in a research report issued to clients and investors on Friday,Benzinga reports. Wall Street Zen downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, August 1st. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Get Teleflex alerts:View Our Latest Analysis on TFXTeleflex Price PerformanceShares of Teleflex stock traded down $3.48 during trading hours on Friday, reaching $135.41. Teleflex Company Profile(Get Free Report)Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery.